Oramed Pharmaceuticals
ORMP
#9012
Rank
โ‚น19.95 B
Marketcap
โ‚น487.50
Share price
6.02%
Change (1 day)
156.43%
Change (1 year)

Market capitalization of Oramed Pharmaceuticals (ORMP)

Market cap: โ‚น19.95 Billion

As of August 2026 Oramed Pharmaceuticals has a market cap of โ‚น19.95 Billion. This makes Oramed Pharmaceuticals the world's 9012th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Oramed Pharmaceuticals from 2008 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚น19.95 B89.07%
2025โ‚น10.55 B28.75%
2024โ‚น8.19 B5.65%
2023โ‚น7.75 B-80.08%
2022โ‚น38.93 B-3.99%
2021โ‚น40.55 B449.32%
2020โ‚น7.38 B15.54%
2019โ‚น6.39 B75.3%
2018โ‚น3.64 B-55.66%
2017โ‚น8.22 B49%
2016โ‚น5.51 B-16.3%
2015โ‚น6.59 B110.97%
2014โ‚น3.12 B-58.76%
2013โ‚น7.57 B384.73%
2012โ‚น1.56 B50.52%
2011โ‚น1.03 B31.46%
2010โ‚น0.78 B-33.66%
2009โ‚น1.19 B12.51%
2008โ‚น1.05 B

End of Day market cap according to different sources

On Aug 24th, 2026 the market cap of Oramed Pharmaceuticals was reported to be:

โ‚น19.12 Billion
by Nasdaq info icon info icon
โ‚น18.81 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Novo Nordisk
NVO
โ‚น20.330 T 101,797.13%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Sanofi
SNY
โ‚น10.483 T 52,444.19%๐Ÿ‡ซ๐Ÿ‡ท France
Ultragenyx Pharmaceutical
RARE
โ‚น250.61 B 1,156.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
โ‚น99.12 B 396.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Compugen
CGEN
โ‚น25.43 B 27.50%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel